Get the Stockscreener App
155.61
0.93%
1.43
After Hours:
155.61
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $155.61, with a volume of 1.12M.
It is up +0.93% in the last 24 hours and up +25.18% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$154.18
Open:
$153.74
24h Volume:
1.12M
Relative Volume:
0.56
Market Cap:
$17.36B
Revenue:
$2.90B
Net Income/Loss:
$239.11M
P/E Ratio:
73.76
EPS:
2.1097
Net Cash Flow:
$492.62M
1W Performance:
-1.11%
1M Performance:
+25.18%
6M Performance:
+73.30%
1Y Performance:
+76.25%
1-Day Range:
$153.46
$156.33
1-Week Range:
$146.70
$166.25
52-Week Range:
$81.22
$166.25
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
155.61 | 17.36B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
662.24 | 244.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.20 | 155.50B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
397.77 | 57.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
171.33 | 48.30B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.21 | 43.16B | 16.63B | 1.39B | 2.12B | 8.0674 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-06-26 | Initiated | William Blair | Outperform |
| Sep-09-26 | Resumed | UBS | Neutral |
| Sep-01-26 | Initiated | RBC Capital Mkts | Sector Perform |
| Jun-26-26 | Resumed | Bernstein | Mkt Perform |
| Jun-02-26 | Resumed | Wolfe Research | Peer Perform |
| Apr-14-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity, Inc. Stock 12‑Month Price Target Raised to $142.93, Implies 6% Downside - TradingView
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo! Finance Canada
What Does Revvity (NYSE:RVTY) New Assay Add to NYSE Composite? - Kalkine Media
Baird Adjusts Price Target on Revvity to $164 From $144 - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
T. Rowe Price reports sole voting power over 12.9M shares in Revvity (RVTY). - Stock Titan
Revvity Inc (RVTY) Stock Earnings Transcripts - GuruFocus
Revvity Inc at Barclays Global Healthcare Conference Transcript - GuruFocus
Revvity Earnings Preview: What to Expect - Barchart.com
What's Going On With Revvity Stock Tuesday?Revvity (NYSE:RVTY) - Benzinga
Barclays Adjusts Price Target on Revvity to $160 From $115, Maintains Equalweight Rating - Yahoo Finance
Revvity to Host Investor Day - Business Wire
Revvity to Host Investor Day - Yahoo Finance
William Blair Initiates Revvity at Outperform - Yahoo Finance
Revvity Inc (RVTY) Stock Up 3.9% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Revvity Inc (MIL:1RVTY) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Revvity Inc Stock Operating Data - GuruFocus
Who's Buying or Selling Revvity Inc (MIL:1RVTY) Stock Today? - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity Inc (MIL:1RVTY) Stock Price, Trades & News - GuruFocus
Revvity Inc (RVTY) VP and Chief Accounting Officer Anita Gonzales Sells 84 Shares - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
A planned 84-share sale leaves Revvity (RVTY) officer holding 7,117 shares directly. - Stock Titan
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? - Zacks Investment Research
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity to Hold Earnings Call on November 3, 2026 - Carroll County Mirror-Democrat
Revvity to Hold Earnings Call on November 3, 2026 - Business Wire
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
An officer proposes selling 84 Revvity (NYSE: RVTY) shares valued at $13.1K. - Stock Titan
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.
Cloud Fails To Upend Revvity's $4.5M Fee, Contract Win - Law360
Revvity Inc. stock outperforms competitors on strong trading day - marketwatch.com
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Yahoo Finance
Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings? - TradingView
PKI4882935 Bond Profile: Coupon and Redemption - TradingView
RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection - Yahoo Finance
Full Transcript: Revvity Q2 2026 Earnings Call - Benzinga
Revvity Inc (RVTY) Shares Surge 6.0% -- What GF Score of 78 Tells Investors - GuruFocus
Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years - Benzinga
Revvity shares rise as analyst target hike adds to momentum from deal and guidance - Quiver Quantitative
Revvity Inc. stock outperforms competitors on strong trading day - marketwatch.com
Revvity Inc stock hits 52-week high at 149.72 USD - Investing.com
Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test - finance.yahoo.com
Revvity, Inc. Launches GSP® T1D 3plex Kit For Early Detection Of Type 1 Diabetes - marketscreener.com
RVTY Looks 20.9% Overvalued on GF Value™ as Insider Selling Pers - GuruFocus
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Revvity Inc Stock (RVTY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Gonzales Anita | Officer |
Oct 01 '26 |
Proposed Sale |
155.48 |
84 |
13,060 |
0 |
| Krakowiak Maxwell | Officer |
Sep 21 '26 |
Proposed Sale |
144.53 |
1,631 |
235,728 |
0 |
| Krakowiak Maxwell | Please See Remarks |
Sep 21 '26 |
Sale |
144.53 |
1,631 |
235,728 |
14,781 |
| Vohra Tajinder S | Please See Remarks |
Sep 16 '26 |
Sale |
140.88 |
7,330 |
1,032,650 |
6,635 |
| Vohra Tajinder S | Officer |
Sep 16 '26 |
Proposed Sale |
140.88 |
7,330 |
1,032,650 |
0 |
| Gonzales Anita | Officer |
Jul 20 '26 |
Proposed Sale |
109.48 |
85 |
9,306 |
0 |
| Gonzales Anita | Vice President and CAO |
Jul 20 '26 |
Sale |
109.48 |
85 |
9,306 |
7,201 |
| Gonzales Anita | Officer |
Apr 20 '26 |
Proposed Sale |
92.80 |
80 |
7,424 |
0 |
| Gonzales Anita | Vice President and CAO |
Apr 20 '26 |
Sale |
92.80 |
80 |
7,424 |
7,319 |
| Victor Miriame | Please See Remarks |
Feb 24 '26 |
Option Exercise |
95.74 |
1,862 |
178,268 |
19,984 |
1.31%
2.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):